Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HSV-2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00465205
What this trial is testing

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

Who this might be right for
HIV InfectionsHerpes SimplexSexually Transmitted Diseases
University of Washington 20
Not applicableStudy completedNCT02986802
What this trial is testing

Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy Outcomes

Who this might be right for
HSV-2 InfectionPreTerm BirthPregnancy Complications
Kaiser Permanente 89,132
Post-approval studies (Phase 4)Study completedNCT00527618
What this trial is testing

Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV

Who this might be right for
Genital HerpesHIV Infection
University of Washington 28
Testing effectiveness (Phase 2)Study completedNCT00740584
What this trial is testing

Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.

Who this might be right for
HIV InfectionsHSV-2 Genital Herpes
Starpharma Pty Ltd 12
Post-approval studies (Phase 4)Study completedNCT01346475
What this trial is testing

Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

Who this might be right for
Genital Herpes
University of Washington 50
Early research (Phase 1)Study completedNCT06698575
What this trial is testing

Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes Simplex Type 2
Assembly Biosciences 103
Testing effectiveness (Phase 2)Study completedNCT02114060
What this trial is testing

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 310
Not applicableStudy completedNCT02455583
What this trial is testing

An Assessment of an HIV Prevention Intervention (Project AIM) Among Junior Secondary School Students in Eastern Botswana

Who this might be right for
HIV
Centers for Disease Control and Prevention 4,732
Testing effectiveness (Phase 2)Study completedNCT00371592
What this trial is testing

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

Who this might be right for
HIV InfectionsHerpesvirus 2, Human
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00274300
What this trial is testing

Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

Who this might be right for
HSV-2
PowderMed 36
Early research (Phase 1)Enrolling By InvitationNCT07330440
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

Who this might be right for
Genital Herpes
Changchun BCHT Biotechnology Co. 144
Large-scale testing (Phase 3)Ended earlyNCT00122525
What this trial is testing

Effect of Male Circumcision on HIV Incidence (ANRS 1265)

Who this might be right for
HIV InfectionsHerpes GenitalisVenereal Diseases
French National Agency for Research on AIDS and Viral Hepatitis 3,274
Early research (Phase 1)Study completedNCT05989672
What this trial is testing

A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years

Who this might be right for
Herpes Simplex
GlaxoSmithKline 50
Testing effectiveness (Phase 2)Study completedNCT01667341
What this trial is testing

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 143
Testing effectiveness (Phase 2)Study completedNCT00405821
What this trial is testing

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda

Who this might be right for
HIV InfectionsHerpes Genitalis
National Institute of Allergy and Infectious Diseases (NIAID) 440
Testing effectiveness (Phase 2)Ended earlyNCT01658826
What this trial is testing

Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes

Who this might be right for
Genital Herpes
AiCuris Anti-infective Cures AG 91
Testing effectiveness (Phase 2)UnknownNCT04714060
What this trial is testing

UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals

Who this might be right for
Recurrent Genital Herpes
UBP Greater China (Shanghai) Co., Ltd 44
Post-approval studies (Phase 4)Ended earlyNCT00495716
What this trial is testing

Effect of HSV-2 Suppressive Therapy on Sexual Behavior

Who this might be right for
Genital Herpes
University of Washington 72
Not applicableStudy completedNCT04664127
What this trial is testing

Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel

Who this might be right for
HerpesHerpes SimplexHerpes Oral+2 more
Nearmedic Plus LLC 45
Not applicableEnded earlyNCT00138320
What this trial is testing

Herpevac Neonatal Substudy

Who this might be right for
Herpes Simplex
National Institute of Allergy and Infectious Diseases (NIAID) 6
Next Page